Skip to main content

Ventricular dysfunction after cardioplegic arrest is improved after myocardial gene transfer of a beta-adrenergic receptor kinase inhibitor.

Publication ,  Journal Article
Tevaearai, HT; Eckhart, AD; Shotwell, KF; Wilson, K; Koch, WJ
Published in: Circulation
October 23, 2001

BACKGROUND: Acute cardiac contractile dysfunction is common after cardiopulmonary bypass (CPB). A potential molecular mechanism is enhanced beta-adrenergic receptor kinase (betaARK1) activity, because beta-adrenergic receptor (betaAR) signaling is altered in cardiomyocytes after cardioplegia. Therefore, we examined whether adenovirus-mediated intracoronary delivery of a betaARK1 inhibitor (Adv-betaARKct) could prevent post-CPB dysfunction. METHODS AND RESULTS: Rabbits were randomized to receive 5x10(11) total viral particles of Adv-betaARKct or PBS. After 5 days, hearts were arrested with University of Wisconsin solution, excised, and stored at 4 degrees C for 15 minutes or 4 hours before reperfusion on a Langendorff apparatus. Left ventricular (LV) function measured by end-diastolic pressure response to preload augmentation, contractility (LV dP/dt(max)), and relaxation (LV dP/dt(min)) was assessed by use of increasing doses of isoproterenol and compared with a control group of nonarrested hearts acutely perfused on the Langendorff apparatus. In the PBS-treated hearts, LV function decreased in a temporal manner and was significantly impaired compared with control hearts after 4 hours of cardioplegic arrest. LV function in Adv-betaARKct-treated hearts, however, was significantly enhanced compared with PBS treatment and was similar to control nonarrested hearts even after 4 hours of cardioplegia. Biochemically, several aspects of betaAR signaling were dysfunctional in PBS-treated hearts, whereas they were normalized in betaARKct-overexpressing hearts. CONCLUSIONS: Myocardial gene transfer of Adv-betaARKct stabilizes betaAR signaling and prevents LV dysfunction induced by prolonged cardioplegic arrest. Thus, betaARK1 inhibition may represent a novel target in limiting depressed ventricular function after CPB.

Duke Scholars

Published In

Circulation

DOI

EISSN

1524-4539

Publication Date

October 23, 2001

Volume

104

Issue

17

Start / End Page

2069 / 2074

Location

United States

Related Subject Headings

  • beta-Adrenergic Receptor Kinases
  • Ventricular Function, Left
  • Ventricular Dysfunction
  • Treatment Outcome
  • Recombinant Proteins
  • Rabbits
  • RNA, Messenger
  • Peptide Fragments
  • Myocardium
  • Myocardial Reperfusion
 

Citation

APA
Chicago
ICMJE
MLA
NLM
Tevaearai, H. T., Eckhart, A. D., Shotwell, K. F., Wilson, K., & Koch, W. J. (2001). Ventricular dysfunction after cardioplegic arrest is improved after myocardial gene transfer of a beta-adrenergic receptor kinase inhibitor. Circulation, 104(17), 2069–2074. https://doi.org/10.1161/hc4201.097188
Tevaearai, H. T., A. D. Eckhart, K. F. Shotwell, K. Wilson, and W. J. Koch. “Ventricular dysfunction after cardioplegic arrest is improved after myocardial gene transfer of a beta-adrenergic receptor kinase inhibitor.Circulation 104, no. 17 (October 23, 2001): 2069–74. https://doi.org/10.1161/hc4201.097188.
Tevaearai HT, Eckhart AD, Shotwell KF, Wilson K, Koch WJ. Ventricular dysfunction after cardioplegic arrest is improved after myocardial gene transfer of a beta-adrenergic receptor kinase inhibitor. Circulation. 2001 Oct 23;104(17):2069–74.
Tevaearai, H. T., et al. “Ventricular dysfunction after cardioplegic arrest is improved after myocardial gene transfer of a beta-adrenergic receptor kinase inhibitor.Circulation, vol. 104, no. 17, Oct. 2001, pp. 2069–74. Pubmed, doi:10.1161/hc4201.097188.
Tevaearai HT, Eckhart AD, Shotwell KF, Wilson K, Koch WJ. Ventricular dysfunction after cardioplegic arrest is improved after myocardial gene transfer of a beta-adrenergic receptor kinase inhibitor. Circulation. 2001 Oct 23;104(17):2069–2074.

Published In

Circulation

DOI

EISSN

1524-4539

Publication Date

October 23, 2001

Volume

104

Issue

17

Start / End Page

2069 / 2074

Location

United States

Related Subject Headings

  • beta-Adrenergic Receptor Kinases
  • Ventricular Function, Left
  • Ventricular Dysfunction
  • Treatment Outcome
  • Recombinant Proteins
  • Rabbits
  • RNA, Messenger
  • Peptide Fragments
  • Myocardium
  • Myocardial Reperfusion